The cumulative incidence of eczema was similar, 36% in the treated vs. 34% in the placebo group. The probiotic group had less IgE-associated eczema during the second year, 8% vs. 20% (P = 0.02),. This evidence concerns the gene IGHE and Eczematoid dermatitis.